No actionable signal from this insider cluster. The open-market selling is de minimis and the non-cash transactions are routine compensation events. Monitor upcoming quarterly earnings for any fundamental changes in TAVR or TMTT performance, but this filing provides no edge.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 5 $82.91entry
- T+1 · 7mo ago +0.35%α −1.04% · $83.20
- T+5 · 6mo ago −3.84%α −5.83% · $79.73
- T+20 · 6mo ago +3.73%α −0.48% · $86.00
- T+60 · 4mo ago +3.81%α +0.60% · $86.07
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two Edwards Lifesciences insiders sold a combined $133K in open-market sales over a 7-day window, representing a trivial 0.0003% of the $44.4B market cap. The cluster is dominated by non-cash transactions (tax withholdings, option exercises, grants, and gifts) from multiple executives and directors, which carry zero economic signal. The open-market selling is immaterial relative to company size and does not indicate insider concern.
Key Financial Metrics
Key Facts
- Two insiders sold $133K total in open-market sales: CVP JAPAC Markowitz Wayne ($47K) and CVP TAVR Lippis Daniel J. ($86K)
- Total open-market sales represent ~0.0003% of EW's $44.4B market cap, trivial and routine
- Cluster includes 18 non-cash transactions: tax withholdings (F), option exercises (M), grants (A), and gifts (G) totaling $0 economic value
- CEO Bernard Zovighian gifted 5,489 shares, no market signal
- CFO Scott Ullem exercised 19,830 options and surrendered 11,004 shares for tax withholding, routine compensation cycle
Financial Impact
Open-market sales of $133K are negligible relative to $44.4B market cap
Risk Factors
- No material insider risk identified from this cluster
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-EW-1778619063246 |
Track record
27 reports on EW
1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +4.94% at T+5 after the Nov 4, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 10, 20266d ago Insider Cluster Neutral 3/10 Entry $105.81 Now $107.11 +1.23% settles Nov 18
- Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $105.81 Now $107.11 +1.23% settles Nov 18
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $105.81 Now $107.11 +1.23% settles Nov 18
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $104.01 Now $107.11 +2.98% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 3/10 Entry $104.01 Now $107.11 +2.98% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $104.01 Now $107.11 +2.98% settles Nov 17
- Nov 4, 202612d ago 8-K Bullish 6/10 Entry $100.82 to $105.80 Now $107.11 +6.24% ▲ +4.94% +1.65% vs SPY
- Oct 29, 202618d ago Institutional Cluster Neutral 3/10 Entry $94.44 to $100.82 Now $107.11 +13.42% ▲ +6.76% +11.48% vs SPY
- Aug 31, 202611w ago Insider Cluster Neutral 2/10 Entry $90.74 to $86.18 Now $107.11 +18.04% ▼ −5.03% −5.11% vs SPY
- Aug 28, 202611w ago Insider Cluster Neutral 2/10 Entry $90.75 to $86.72 Now $107.11 +18.03% ▼ −4.44% −4.30% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers